FDA on Thursday (May 21) listed 27 COVID-19 antibody tests that no longer are on the market under FDA’s March 16 policy that allowed tests to be marketed and distributed without FDA authorization as long as the manufacturers notified the agency. The list includes tests that were voluntarily withdrawn by the manufacturers, as well as those for which there are no pending Emergency Use Authorization requests or issued EUAs. The tests on the removal list will not be marketed or...